1. Abuse potential of mirogabalin in recreational polydrug users. (April 2019) Authors: Mendell, Jeanne; Levy-Cooperman, Naama; Sellers, Ed; Vince, Bradley; Kelsh, Debra; Lee, James; Warren, Vance; Zahir, Hamim Journal: Therapeutic advances in drug safety Issue: Volume 10(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Coadministration of probenecid and cimetidine with mirogabalin in healthy subjects: A phase 1, randomized, open‐label, drug–drug interaction study. (9th August 2018) Authors: Tachibana, Masaya; Yamamura, Naotoshi; Atiee, George J.; Hsu, Ching; Warren, Vance; He, Ling; Dishy, Victor; Zahir, Hamim Journal: British journal of clinical pharmacology Issue: Volume 84:Number 10(2018) Page Start: 2317 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Dosing Recommendation Based on the Effects of Different Meal Types on Pexidartinib Pharmacokinetics in Healthy Subjects: Implementation of Model‐informed Drug Development Strategy. Issue 5 (21st March 2023) Authors: Zahir, Hamim; Yin, Ophelia; Hsu, Ching; Wagner, Andrew J.; Jiang, Jason; Wang, Xiaoning; Greenberg, Jon; Shuster, Dale E.; Kakkar, Tarundeep; LaCreta, Frank Journal: Clinical pharmacology in drug development Issue: Volume 12:Issue 5(2023) Page Start: 475 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Edoxaban drug–drug interactions with ketoconazole, erythromycin, and cyclosporine. (23rd September 2016) Authors: Parasrampuria, Dolly A.; Mendell, Jeanne; Shi, Minggao; Matsushima, Nobuko; Zahir, Hamim; Truitt, Kenneth Journal: British journal of clinical pharmacology Issue: Volume 82:Number 6(2016:Dec.) Page Start: 1591 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Edoxaban Effects on Bleeding Following Punch Biopsy and Reversal by a 4-Factor Prothrombin Complex Concentrate. Issue 1 (6th January 2015) Authors: Zahir, Hamim; Brown, Karen S.; Vandell, Alexander G.; Desai, Madhuri; Maa, Jen-Fue; Dishy, Victor; Lomeli, Barbara; Feussner, Annette; Feng, Wenqin; He, Ling; Grosso, Michael A.; Lanz, Hans J.; Antman, Elliott M. Journal: Circulation Issue: Volume 131:Issue 1(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Edoxaban Effects on Bleeding Following Punch Biopsy and Reversal by a 4-Factor Prothrombin Complex Concentrate. Issue 1 (6th January 2015) Authors: Zahir, Hamim; Brown, Karen S.; Vandell, Alexander G.; Desai, Madhuri; Maa, Jen-Fue; Dishy, Victor; Lomeli, Barbara; Feussner, Annette; Feng, Wenqin; He, Ling; Grosso, Michael A.; Lanz, Hans J.; Antman, Elliott M. Journal: Circulation Issue: Volume 131:Issue 1(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Effect of Mild and Moderate Hepatic Impairment (Defined by Child–Pugh Classification and National Cancer Institute Organ Dysfunction Working Group Criteria) on Pexidartinib Pharmacokinetics. (31st March 2022) Authors: Zahir, Hamim; Greenberg, Jonathan; Hsu, Ching; Marbury, Thomas C.; Lasseter, Kenneth C.; Xu, Li‐An; Tap, William D.; Healey, John H.; Stacchiotti, Silvia; LaCreta, Frank Journal: Journal of clinical pharmacology Issue: Volume 62:Number 8(2022) Page Start: 992 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Evaluation of Potential Drug‐Drug Interaction Risk of Pexidartinib With Substrates of Cytochrome P450 and P‐Glycoprotein. (12th September 2020) Authors: Zahir, Hamim; Kobayashi, Fumiaki; Zamora, Cynthia; Gajee, Roohi; Gordon, Michael S.; Babiker, Hani M.; Wang, Qiang; Greenberg, Jonathan; Wagner, Andrew J. Journal: Journal of clinical pharmacology Issue: Volume 61:Number 3(2021) Page Start: 298 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Evaluation of the pharmacokinetic drug interaction potential of tivantinib (ARQ 197) using cocktail probes in patients with advanced solid tumours. (29th October 2017) Authors: Tachibana, Masaya; Papadopoulos, Kyriakos P.; Strickler, John H.; Puzanov, Igor; Gajee, Roohi; Wang, Yibin; Zahir, Hamim Journal: British journal of clinical pharmacology Issue: Volume 84:Number 1(2018:Jul.) Page Start: 112 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Exposure–response analysis of efficacy and safety for pexidartinib in patients with tenosynovial giant cell tumor. (14th October 2021) Authors: Yin, Ophelia; Zahir, Hamim; French, Jonathan; Polhamus, Daniel; Wang, Xiaoning; van de Sande, Michiel; Tap, William D.; Gelderblom, Hans; Wagner, Andrew J.; Healey, John H.; Greenberg, Jonathan; Shuster, Dale; Stacchiotti, Silvia Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 10:Number 11(2021) Page Start: 1422 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗